Polaris Partners

Type

Venture Capital

Status

Active

Location

Boston, United States

Total investments

718

Average round size

27M

Portfolio companies

370

Rounds per year

25.64

Lead investments

119

Follow on index

0.48

Exits

161

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareEnterprise SoftwareMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

Polaris Partners appeared to be the VC, which was created in 1996. The leading representative office of defined VC is situated in the Boston. The fund was located in North America if to be more exact in United States.

The fund was created by Jon Flint, Steve Arnold, Terrance McGuire. We also calculated 9 valuable employees in our database.

The typical startup value when the investment from Polaris Partners is 100-500 millions dollars. Comparing to the other companies, this Polaris Partners performs on 9 percentage points less the average number of lead investments. The fund is constantly included in 13-24 deals per year. The higher amount of exits for fund were in 2019. The real fund results show that this VC is 12 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2008.

Among the most popular portfolio startups of the fund, we may highlight Receptos, LegalZoom, Insidesales.com. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Polaris Partners, startups are often financed by Three Arch Partners, New Enterprise Associates, Frontline Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, SR One, Canaan Partners. In the next rounds fund is usually obtained by Sofinnova Investments, Omega Funds, Lilly Ventures.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcare
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
718
Lead investments
119
Exits
161
Rounds per year
25.64
Follow on index
0.48
Investments by industry
  • Biotechnology (281)
  • Health Care (274)
  • Medical (140)
  • Software (131)
  • Therapeutics (125)
  • Show 263 more
Investments by region
  • United States (661)
  • Singapore (4)
  • Netherlands (3)
  • Switzerland (2)
  • Ireland (8)
  • Show 9 more
Peak activity year
2008
Number of Unicorns
7
Number of Decacorns
7
Number of Minotaurs
5

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
64M
Group Appearance index
0.88
Avg. company exit year
12
Avg. multiplicator
2.85
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Olivo Laboratories LLC 01 Jan 2016 Personal Health Seed United States, Massachusetts, Watertown
Paddle 14 Dec 2017 Internet, Software, B2B, Payments, SaaS, Apps Early Stage Venture 12M England, London, United Kingdom
SpineZone 02 May 2024 Health Care, Medical Early Stage Venture 15M United States, California, San Diego
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.